在马来西亚对细胞和基因治疗产品的监管监督
Evelyn Yun Xi Loh1, Azizah Ab Ghani2, Rosilawati Ahmad3
1Biologics Section, Centre of Product and Cosmetic Evaluation, National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia, Selangor, Malaysia.
Advances in experimental medicine and biology
|August 1, 2023
概括
马来西亚 马来西亚 马来西亚
科学领域:
- 监管科学 监管科学
- 生物技术是生物技术.
- 制药政策 制药政策
背景情况:
- 马来西亚国家药品监管局 (NPRA) 负责监督产品注册和通知.
- 监管监管逐渐扩大,包括先进疗法.
- 细胞和基因治疗产品 (CGTPs) 于2021年1月1日开始受到监管.
研究的目的:
- 概述马来西亚CGTP的监管框架.
- 详细说明CGTP的分类,注册途径和要求.
- 讨论CGTP监管的现状和未来发展轨迹.
主要方法:
- 审查CGTP框架的时间发展.
- 对CGTP分类的分析 (低风险与高风险).
- 审查生物产品现有的注册程序和档案要求.
主要成果:
- CGTP被分为低风险 (没有注册) 或高风险 (需要注册).
- 高风险的CGTP法规与现有的生物产品指南保持一致.
- 该框架将CGTP整合到马来西亚目前的监管途径中.
结论:
- 马来西亚已经为CGTPs建立了一个结构化的监管框架.
- 该框架适用于低风险和高风险的CGTP.
- 该NPRA的位置是管理细胞和基因疗法的不断变化的景观.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K
Drug Control Governance: Regulatory Bodies and Their Impact
184
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
184
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


